Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
64.5M
-
Shares change
-
+849K
-
Total reported value, excl. options
-
$2.72B
-
Value change
-
+$34.7M
-
Put/Call ratio
-
0.95
-
Number of buys
-
113
-
Number of sells
-
-95
-
Price
-
$42.18
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2014
244 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2014.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.5M shares
of 71.9M outstanding shares and own 89.63% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.63M shares), Neuberger Berman Group LLC (5.48M shares), FRANKLIN RESOURCES INC (4.44M shares), BlackRock Fund Advisors (3.67M shares), State Street Corp (2.98M shares), KALMAR INVESTMENTS INC /DE/ (2.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.99M shares), BlackRock Institutional Trust Company, N.A. (1.88M shares), BAMCO INC /NY/ (1.8M shares), and RENAISSANCE TECHNOLOGIES LLC (1.61M shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.